Derleme
BibTex RIS Kaynak Göster

Acute fibrinosis and organized pneumonia

Yıl 2024, , 144 - 146, 30.04.2024
https://doi.org/10.47582/jompac.1460019

Öz

Acute fibrinous and organizing pneumonia (AFOP), first described histologically by Beasley et al.1 in 2002. AFOP occurs in a wide age range (38-78 age) and in a non-sexist spectrum of patients. Although idiopathic cases have been reported, case series in which the underlying etiology is known. The histologically specific pattern is the presence of organized intra-alveolar fibrin and is the essential parameter for diagnosis. There is no significant difference in the radiological pattern except for the
halo finding in the comparison of AFOP and COP. In patients presenting with an acute and more fulminant picture, the clinic presents with rapidly worsening respiratory failure. The main complaints were fever, cough and chest pain respectively. Since AFOP is a diagnosis of exclusion, most patients are diagnosed with pneumonia that does not respond to treatment or has delayed resolution during follow up. Although the clinical presentations of the fulminant and subacute forms of AFOP are different, a clear distinction cannot be made for treatment due to the high mortality of the fulminant form. The prognosis is poor in acute fulminant cases.

Kaynakça

  • 1. Beasley MB, Franks TJ, Galvin JR, Gochuico B, Travis WD. Acute fibrinous and organizing pneumonia a histologic pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Laborat Med. 2002;126(9):1064-1070.
  • 2. Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18-e47.
  • 3. Wang Y, Li Y, Wang Q, et al. Acute fibrinous and organizing pneumonia; a case report. Medicine. 2019;98(8):e14537.
  • 4. Onishi Y, Kawamura T, Higashino T, Mimura R, Tsukamoto H, Sasaki S. Clinical features of acute fibrinous and organizing pneumonia: an early histologic pattern of various acute inflammatory lung diseases. PLoS One. 2021;16(4):e0249300.
  • 5. Gomes R, Padrão E, Dabó H, et al. Acute fibrinous and organizing pneumonia: a report of 13 cases in a tertiary university hospital. Medicine. 2016;95(27):e4073.
  • 6. Simmons GL, Chung HM, McCarty JM, et al. Treatment of acute fibrinous organizing pneumonia following hematopoietic cell transplantation with etanercept. Bone Marrow Transplant. 2017;52(1):141-143.
  • 7. Kumar S, Mishra M, Goyal K, Bhatt R, Joshi P, Bansal S. Acute fibrinous organizing pneumonia: a rare lung pathology. Monaldi Arch Chest Dis. 2019;89(2):1016.
  • 8. Ford D, Charoenpong P, Boparai S. Acute fibrinous organizing pneumonia: a new association. Chest. 2021;160(4):A1654.
  • 9. Kuza C, Matheos T, Kathman D, Heard SO. Life after acute fibrinous and organizing pneumonia: a case report of a patient 30 months after diagnosis and review of the literature. J Crit Care. 2016;31(1):255-261.
  • 10. Damas C, Morais A, Moura CS, Marques JA. Acute fibrinous and organizing pneumonia. Pulmonol. 2006;12(5):615-620.
  • 11. Lu J, Yin Q, Zha Y, et al. Acute fibrinous and organizing pneumonia: two case reports and literature review. BMC Pulm Med. 2019;19(1):141.
  • 12. Onishi Y, Kawamura T, Nakahara Y, et al. Factors associated with the relapse of cryptogenic and secondary organizing pneumonia. Respir Investig 2017;55(1):10-15.
  • 13. Sauter JL, Butnor KJ. Expanding the spectrum of pulmonary histopathological manifestations of antisynthetase syndrome: anti-EJ-associated acute fibrinous and organizing pneumonia. Histopathol. 2014;65(4):581-582.
  • 14. Ning YJ, Ding PS, Ke ZY, Zhang YB, Liu RY. Successful steroid treatment for acute fibrinous and organizing pneumonia: a case report. World J Clin Cases. 2018;6(15):1053-1058.

Akut fibrinöz ve organize pnömoni

Yıl 2024, , 144 - 146, 30.04.2024
https://doi.org/10.47582/jompac.1460019

Öz

Akut fibrinöz ve organize pnömoni (AFOP), ilk kez histolojik olarak Beasley ve ark. tarafından tanımlanmıştır. AFOP geniş bir yaş aralığında (38-78 yaş) ve cinsiyetçi olmayan bir hasta yelpazesinde ortaya çıkmaktadır. İdiyopatik olgular bildirilse de altta yatan etiyolojinin bilindiği olgu serileri de mevcuttur. Histolojik olarak spesifik patern, organize intraalveoler fibrinin varlığıdır ve tanı için temel parametredir. AFOP ve COP karşılaştırıldığında halo bulgusu dışında radyolojik paternde anlamlı bir fark yoktur. Akut ve daha fulminan bir tabloyla başvuran hastalarda klinik hızla kötüleşen solunum yetmezliği ile karşımıza çıkmaktadır. Başlıca şikayetler sırasıyla ateş, öksürük ve göğüs ağrısıydı. AFOP bir dışlama tanısı olduğu için çoğu hastaya tedaviye yanıt vermeyen veya takip sırasında iyileşmesi geciken pnömoni tanısı konur. AFOP'un fulminan ve subakut formlarının klinik tabloları farklı olsa da fulminan formun mortalitesinin yüksek olması nedeniyle tedavide net bir ayrım yapılamamaktadır. Akut fulminan vakalarda prognoz kötüdür.

Kaynakça

  • 1. Beasley MB, Franks TJ, Galvin JR, Gochuico B, Travis WD. Acute fibrinous and organizing pneumonia a histologic pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Laborat Med. 2002;126(9):1064-1070.
  • 2. Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18-e47.
  • 3. Wang Y, Li Y, Wang Q, et al. Acute fibrinous and organizing pneumonia; a case report. Medicine. 2019;98(8):e14537.
  • 4. Onishi Y, Kawamura T, Higashino T, Mimura R, Tsukamoto H, Sasaki S. Clinical features of acute fibrinous and organizing pneumonia: an early histologic pattern of various acute inflammatory lung diseases. PLoS One. 2021;16(4):e0249300.
  • 5. Gomes R, Padrão E, Dabó H, et al. Acute fibrinous and organizing pneumonia: a report of 13 cases in a tertiary university hospital. Medicine. 2016;95(27):e4073.
  • 6. Simmons GL, Chung HM, McCarty JM, et al. Treatment of acute fibrinous organizing pneumonia following hematopoietic cell transplantation with etanercept. Bone Marrow Transplant. 2017;52(1):141-143.
  • 7. Kumar S, Mishra M, Goyal K, Bhatt R, Joshi P, Bansal S. Acute fibrinous organizing pneumonia: a rare lung pathology. Monaldi Arch Chest Dis. 2019;89(2):1016.
  • 8. Ford D, Charoenpong P, Boparai S. Acute fibrinous organizing pneumonia: a new association. Chest. 2021;160(4):A1654.
  • 9. Kuza C, Matheos T, Kathman D, Heard SO. Life after acute fibrinous and organizing pneumonia: a case report of a patient 30 months after diagnosis and review of the literature. J Crit Care. 2016;31(1):255-261.
  • 10. Damas C, Morais A, Moura CS, Marques JA. Acute fibrinous and organizing pneumonia. Pulmonol. 2006;12(5):615-620.
  • 11. Lu J, Yin Q, Zha Y, et al. Acute fibrinous and organizing pneumonia: two case reports and literature review. BMC Pulm Med. 2019;19(1):141.
  • 12. Onishi Y, Kawamura T, Nakahara Y, et al. Factors associated with the relapse of cryptogenic and secondary organizing pneumonia. Respir Investig 2017;55(1):10-15.
  • 13. Sauter JL, Butnor KJ. Expanding the spectrum of pulmonary histopathological manifestations of antisynthetase syndrome: anti-EJ-associated acute fibrinous and organizing pneumonia. Histopathol. 2014;65(4):581-582.
  • 14. Ning YJ, Ding PS, Ke ZY, Zhang YB, Liu RY. Successful steroid treatment for acute fibrinous and organizing pneumonia: a case report. World J Clin Cases. 2018;6(15):1053-1058.
Toplam 14 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Göğüs Hastalıkları
Bölüm Review [en] Derleme [tr]
Yazarlar

Kerem Ensarioğlu 0000-0002-0968-1549

Berna Akıncı Özyürek 0000-0003-0206-7615

Yayımlanma Tarihi 30 Nisan 2024
Gönderilme Tarihi 27 Mart 2024
Kabul Tarihi 25 Nisan 2024
Yayımlandığı Sayı Yıl 2024

Kaynak Göster

AMA Ensarioğlu K, Akıncı Özyürek B. Acute fibrinosis and organized pneumonia. J Med Palliat Care / JOMPAC / Jompac. Nisan 2024;5(2):144-146. doi:10.47582/jompac.1460019

images?q=tbn:ANd9GcRrI_RWgGRe7JRpz3PAnkt2YEFD2l6WEmgHMzuM2w9b&s

f9ab67f.png     

7yziemq.png




COPE.jpg

icmje_1_orig.png

cc.logo.large.png

ncbi.png

ORCID_logo.png

images?q=tbn:ANd9GcQk2AsOdjP67NBkYAqd8FHwCmh0_3dkMrXh3mFtfPKXwIai7h0lIds8QYM9YjKMhZw8iP0&usqp=CAU

logo_world_of_journals_no_margin.png1280px-WorldCat_logo.svg.png                             images?q=tbn:ANd9GcRrI_RWgGRe7JRpz3PAnkt2YEFD2l6WEmgHMzuM2w9b&s


Dergimiz; TR-Dizin ULAKBİM, ICI World of  Journal's, Index Copernicus, Directory of Research Journals Indexing (DRJI), General Impact Factor, Google Scholar, Researchgate, WorldCat (OCLC), CrossRef (DOI), ROAD, ASOS İndeks, Türk Medline İndeks, Eurasian Scientific Journal Index (ESJI) ve Türkiye Atıf Dizini'nde indekslenmektedir.

EBSCO, DOAJ, OAJI, ProQuest dizinlerine müracaat yapılmış olup, değerlendirme aşamasındadır.

Makaleler "Çift-Kör Hakem Değerlendirmesi”nden geçmektedir.

Üniversitelerarası Kurul (ÜAK) Eşdeğerliği: Ulakbim TR Dizin'de olan dergilerde yayımlanan makale [10 PUAN] ve 1a, b, c hariç uluslararası indekslerde (1d) olan dergilerde yayımlanan makale [5 PUAN].

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser.  About predatory/questionable journals and journal charge policy

Not: Dergimiz WOS indeksli değildir ve bu nedenle Q  sınıflamasına dahil değildir.
Yağmacı/şüpheli dergilerle ilgili Yüksek Öğretim Kurumu (YÖK) kararları ve yazar açıklama metni ile dergi ücret politikası: Yağmacı/Şaibeli Dergiler ve Dergi Ücret Politikası